ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,448Medicare Part D Prescriptions Filled, Including Refills

Rank: 341 out of 2061

$758K Total Retail Price of All Prescriptions

Rank: 284 out of 2061

520 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 520 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 520 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,528 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 747 701 1 1
ATORVASTATIN CALCIUM 606 568 2 8
LISINOPRIL 510 479 3 2
LEVOTHYROXINE SODIUM 412 388 4 3
LOSARTAN POTASSIUM 368 334 5 17
AMLODIPINE BESYLATE 359 341 6 4
OMEPRAZOLE 275 268 7 5
ZOLPIDEM TARTRATE 221 193 8 23
HYDROCHLOROTHIAZIDE 207 206 9 12
PRAVASTATIN SODIUM 177 174 10 14
BISOPROLOL FUMARATE 170 170 11 246
FUROSEMIDE 168 148 12 6
GABAPENTIN 159 146 13 15
CITALOPRAM HBR 154 144 14 20
CRESTOR 141 112 15 31
CALCITRIOL 133 122 16 208
METOPROLOL SUCCINATE 132 126 17 19
HYDROCODONE-ACETAMINOPHEN 126 116 S3 18 10
KLOR-CON M20 120 120 19 47
TRAZODONE HCL 117 108 20 39
TAMSULOSIN HCL 115 109 21 30
POTASSIUM CHLORIDE 115 115 21 16
AMLODIPINE BESYLATE-BENAZEPRIL 111 102 23 79
LIPITOR 111 102 23 70
DIOVAN 109 103 25 41
LOSARTAN-HYDROCHLOROTHIAZIDE 102 95 26 50
ATENOLOL 101 98 27 13
ALLOPURINOL 97 95 28 28
TRIAMTERENE-HCTZ 97 90 28 38
CARVEDILOL 93 84 30 22
NEXIUM 93 81 30 26
METHYLPREDNISOLONE 92 87 32 101
DONEPEZIL HCL 88 88 33 24
WARFARIN SODIUM 88 88 33 11
RAMIPRIL 87 77 35 95
ZETIA 87 81 35 68
OXYCODONE-ACETAMINOPHEN 85 67 S2 37 36
METOPROLOL TARTRATE 85 75 37 7
FENOFIBRATE 83 65 39 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 75 40 27
FINASTERIDE 79 79 40 86
CIPROFLOXACIN HCL 74 69 42 54
FLUTICASONE PROPIONATE 74 66 42 43
SYNTHROID 73 72 44 58
CEFUROXIME 69 64 45 170
BISOPROLOL-HYDROCHLOROTHIAZIDE 68 59 46 152
SPIRIVA 68 68 46 63
MELOXICAM 67 67 48 44
PANTOPRAZOLE SODIUM 67 50 48 45
BENAZEPRIL HCL 61 61 50 124
EVISTA 60 60 51 150
SERTRALINE HCL 57 54 52 21
LEVOFLOXACIN 57 54 52 111
METFORMIN HCL 56 45 54 9
TRIAMCINOLONE ACETONIDE 53 50 55 172
CLOPIDOGREL 51 51 56 29
LABETALOL HCL 50 50 57 161
TERAZOSIN HCL 50 46 57 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.